In Brief
-
Lab coats for new bioscience students
First-year PhD students in the 14 bioscience programs and in bioengineering attended the lab coat ceremony on Sept. 30.
-
Public health impact of e-cigarettes subject of Oct. 26 forum
National health experts will debate whether e-cigarettes will improve public health by replacing tobacco cigarettes or damage public health by renormalizing smoking.
-
Deveare Smith, Carrion to discuss problem of school-to-prison pipeline Oct. 23
Playwright and actress Anna Deavere Smith, whose latest work is called The Pipeline Project, will be in conversation with psychiatrist Victor Carrion, MD, an expert on childhood stress and trauma.
-
Committee appointed to search for next CEO of Stanford Health Care
The committee will be co-chaired by John Levin, chair of the SHC Board of Directors, and Lloyd Minor, MD, dean of the School of Medicine.
-
More than $500,000 for projects on pediatric cancer
The funding from the St. Baldrick’s Foundation supports research to find cures and better treatments for pediatric cancers.
-
Child Health Research Institute names six faculty scholars
The awards support junior and mid-level faculty whose research aims to improve the health of expectant mothers, embryos, fetuses, infants, children and adolescents.
-
Five projects receive Transdisciplinary Initiatives Program awards
The TIP program supports innovative, heterogeneous groups of scholars working to transform one another’s perspective on a child- or maternal-health problem.
-
Stanford Medicine community invited to Oct. 12 town hall meeting on precision health
Faculty members will discuss the significance of precision health and how their work is helping to advance it during a panel discussion moderated by medical school Dean Lloyd Minor.
-
Sino-U.S. Symposium on Medicine set for Oct. 15-16
Stanford Medicine will host researchers, clinicians, industry experts and policymakers from China and the United States.
-
Researchers awarded $14 million for two precision health projects
Teri Klein and Russ Altman have received NIH funding to expand two ongoing projects that publish information about the connection between patients’ genetics and their responses to prescription drugs.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.